ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2318

Reduced Thymus Function and Accelerated T-Cell Aging in Patients with Axial Spondylarthritis

Christian Dejaco1, Wolfgang Schwinger2, Andrea Raicht2, Rusmir Husic3, Johannes Fessler3, Christoph G. Ammann4, Christina Duftner5, Winfried B. Graninger6 and Michael Schirmer7, 1Rheumatology, Southend University Hospital, Westcliff-on-Sea, United Kingdom, 2Division of Pediatric Hemato-Oncology, Medical University Graz, Graz, Austria, 3Rheumatology, Medical University Graz, Graz, Austria, 4Internal medicine, Medical Uiversity Innsbruck, Innsbruck, Austria, 5Internal Medicine, Hopital Kufstein, Kufstein, Austria, 6Internal medicine/Rheumatology and Immunology, Medical University Graz, Graz, Austria, 7Internal medicine, Innsbruck Medical University, Innsbruck, Austria

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: T cells and spondylarthropathy

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: T-cell Biology and Targets in Autoimmune Disease

Session Type: Abstract Submissions (ACR)

Background/Purpose: To investigate thymic T-cell output, senescence of circulating T-cell subsets and changes of T cell subsets in patients with axial spondylarthritis (aSpA). Results are compared with data from rheumatoid arthritis (RA) patients and healthy controls (HC).

Methods:  Patients with aSpA (n=26; 26.9% female, mean BASDAI 3.2 ±2.1), RA (n=20; 60.0%, mean SDAI 10.2 ±10.2) and HC (n=24; 70.8%) were prospectively enrolled. Naïve and memory CD4+ and CD8+ T-cell subsets were isolated by MACS-technology. DNA was extracted by QIAamp DNA isolation Kit. TREC Analysis was performed with LC 480 Probes Master using established oligonucleotides as primers. Telomere length analysis was performed using LightCycler FastStart DNA Master SYBR Green I with published oligonucleotides as primers for telomere length or for the single copy gene 36B4 as normalizing sequence. The telomere length was calculated by comparison of sample result with a positive control with known telomere length (HEK293 with 5 kbp). FACS analyses were performed on fresh PBMCs in a separate cohort of 25 patients and 24 HC.

Results: aSpA (median age 37.0, range 21.8-69.7 years) and RA (37.0, 21.4-73.6 years) patients did not differ from HC (35.3, 23.3-54.3 years) regarding age and disease duration (aSpA: mean 7.7±6.8, RA 6.4±5.1 years, each with p>0.2). Percentages of circulating TH17, naïve CD45RA+ and memory CD45RO+ CD4+/CD8+ T-cells as well as CD4+FOXP3+ Treg cells did not differ between aSpA patients and healthy controls.

Reduced thymus function as indicated by a lower TREC content in naïve CD3+CD4+CD45RA+ and CD3+CD8+CD45RA+ T-cells was found in aSpA (median 483 copies/ng DNA, range 33-5033 and 462, 15-4467, respectively) and RA patients (355, 0-162800 and 296, 0-71800, respectively) compared to HC (2304, 0-64444 and 2558, 0-103091, respectively; p<0.05 for comparisons between aSpA or RA patients and HC). Trends for an inverse correlation between TREC content in naïve CD4+ or CD8+ T-cells and age were found among RA patients and HC (corrcoeffs ranging from -0.30 to -0.53, p<0.2 for each analysis) but not among aSpA patients (corrcoeffs-0.01-0.07). Shortened telomeres were found in naïve CD45RA+CD4+ and CD8+ (6.24, 5.76-8.13 and 6.15, 5.33-7.56, respectively) as well as memory CD45RO+CD4+ and CD8+ T-cell subsets (5.99, 5.51-8.46 and 6.21, 5.50-7.79, respectively) from aSpA patients compared to HC (CD4+CD45RA+: 7.17, 3.65-8.67, CD8+CD45RA+: 6.99, 3.83-8.47; CD4+CD45RO+: 6.99, 3.70-8.32 and CD8+CD45RO+: 7.20, 3.87-8.06; p<0.05 for each comparison) whereas differences between RA patients and HC concerning telomere length of T-cell subsets did not reach statistical significance.

Conclusion: Thymic T-cell renewal is impaired in aSpA patients. Consequently, increased peripheral T-cell turnover compensates for failing thymus to maintain T-cell homeostasis leading to accelerated telomere erosion and the accumulation of early aged T-cells.


Disclosure:

C. Dejaco,
None;

W. Schwinger,
None;

A. Raicht,
None;

R. Husic,
None;

J. Fessler,
None;

C. G. Ammann,
None;

C. Duftner,
None;

W. B. Graninger,
None;

M. Schirmer,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/reduced-thymus-function-and-accelerated-t-cell-aging-in-patients-with-axial-spondylarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology